185 related articles for article (PubMed ID: 36243674)
1. MRI appearance of combined hepatocellular cholangiocarcinoma.
Billet N; Grégory J; Ronot M
Diagn Interv Imaging; 2022 Dec; 103(12):625-626. PubMed ID: 36243674
[No Abstract] [Full Text] [Related]
2. Multimodality imaging of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Shahbazian H; Mirza-Aghazadeh-Attari M; Borhani A; Mohseni A; Madani SP; Ansari G; Pawlik TM; Kamel IR
J Surg Oncol; 2023 Sep; 128(4):519-530. PubMed ID: 37439096
[TBL] [Abstract][Full Text] [Related]
3. The Growing Interest in the Combined Hepatocellular-intrahepatic Cholangiocarcinoma (cHCC-CCA).
Acalovschi M
J Gastrointestin Liver Dis; 2023 Jun; 32(2):135-138. PubMed ID: 37345590
[No Abstract] [Full Text] [Related]
4. Editorial for "Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas".
Yoon JH
J Magn Reson Imaging; 2023 Jan; 57(1):318-319. PubMed ID: 35604010
[No Abstract] [Full Text] [Related]
5. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
[No Abstract] [Full Text] [Related]
6. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
8. A Ring in the Liver.
Xu J; Liang X; Cai X
Am J Gastroenterol; 2021 Jan; 116(1):220-222. PubMed ID: 32868632
[No Abstract] [Full Text] [Related]
9. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.
Wu Y; Xia C; Chen J; Qin Q; Ye Z; Song B
Abdom Radiol (NY); 2024 Jan; 49(1):34-48. PubMed ID: 37823913
[TBL] [Abstract][Full Text] [Related]
11. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings.
Nishie A; Yoshimitsu K; Asayama Y; Irie H; Aibe H; Tajima T; Shinozaki K; Nakayama T; Kakihara D; Shimada M; Aishima S; Yoshida K; Honda H
AJR Am J Roentgenol; 2005 Apr; 184(4):1157-62. PubMed ID: 15788587
[TBL] [Abstract][Full Text] [Related]
12. [Imaging of intrahepatic cholangiocarcinoma : Reliable diagnosis according to the new S3 guideline].
Geith T; Paprottka PM
Radiologe; 2022 Mar; 62(3):205-209. PubMed ID: 35029722
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
[TBL] [Abstract][Full Text] [Related]
14. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
15. Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.
Joo I; Kim H; Lee JM
Korean J Radiol; 2015; 16(1):50-68. PubMed ID: 25598674
[TBL] [Abstract][Full Text] [Related]
16. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines.
Barreiros AP; Piscaglia F; Dietrich CF
J Hepatol; 2012 Oct; 57(4):930-2. PubMed ID: 22739095
[No Abstract] [Full Text] [Related]
17. Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Chen J; Zhang W; Bao J; Wang K; Zhao Q; Zhu Y; Chen Y
Abdom Radiol (NY); 2024 Jan; 49(1):93-102. PubMed ID: 37999743
[TBL] [Abstract][Full Text] [Related]
18. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
Zhou YM; Yang JM; Wang B; Xu F; Tong Y; Li DQ
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):656-9. PubMed ID: 18086637
[TBL] [Abstract][Full Text] [Related]
19. Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
Shiomi S; Sasaki N; Kawashima D; Jomura H; Fukuda T; Kuroki T; Koyama K; Kawabe J; Ochi H
Clin Nucl Med; 1999 May; 24(5):370-1. PubMed ID: 10232488
[No Abstract] [Full Text] [Related]
20. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]